Cargando…
Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases
BACKGROUND: Chloracne is a rare skin condition that is caused by systemic exposure to halogenated aromatic compounds. The main characteristic of chloracne is blackhead, and in severe cases, it can be accompanied by systemic symptoms. Sodium 3,5,6-trichloropyridin-2-ol (STCP) is a necessary precursor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896668/ https://www.ncbi.nlm.nih.gov/pubmed/33644170 http://dx.doi.org/10.12998/wjcc.v9.i5.1079 |
_version_ | 1783653584427024384 |
---|---|
author | Ma, Yan Cao, Xue Zhang, Li Zhang, Jin-Yu Qiao, Zu-Sha Feng, Wen-Li |
author_facet | Ma, Yan Cao, Xue Zhang, Li Zhang, Jin-Yu Qiao, Zu-Sha Feng, Wen-Li |
author_sort | Ma, Yan |
collection | PubMed |
description | BACKGROUND: Chloracne is a rare skin condition that is caused by systemic exposure to halogenated aromatic compounds. The main characteristic of chloracne is blackhead, and in severe cases, it can be accompanied by systemic symptoms. Sodium 3,5,6-trichloropyridin-2-ol (STCP) is a necessary precursor compound for the production of chlorpyrifos and triclopyr, which are extensively used as a pesticide and herbicide, respectively. STCP is also a chlorophenol that has been associated with chloracne. STCP poisoning could induce mild myelin sheath damage. We herein report three cases with chloracne due to exposure to STCP. CASE SUMMARY: Three young men, aged 29, 33, and 26 years, respectively, in the same workplace had polymorphic skin lesions, characterized mainly by comedones and cysts, and one of them also had acne like lesions in the genital area. These clinical manifestations appeared when they were exposed to STCP for 3 d, 1 wk, and 2 wk, respectively. Among them, polyneuropathy and liver damage occurred. We performed dermoscopy and clinical and laboratory tests on these patients. Additionally, histopathology was used for further diagnosis in the serious patient. These patients were diagnosed with chloracne and separated from STCP. The patients were prescribed oral viaminate capsules, topical adapalene gel, and regular hematologic follow-up for aspartate transaminase and lipids. They are still under follow-up. There was no new lesions and the laboratory tests returned to normal in two patients. Pigmentation and shallow scars remained in the original areas of papules. However, in the most serious patient, new papules still appeared intermittently. All these remind us that the treatment of chloracne caused by STCP is difficult, and we should attach great importance to this new compound related with the neuropathy and chloracne. CONCLUSION: STCP is becoming a new chemical product to induce chloracne, which should attract the attention of all medical professionals, especially dermatologists. Due to the lack of knowledge on the new chemical, the diagnosis of chloracne cannot be made in time. Chloracne still deserves our attention. |
format | Online Article Text |
id | pubmed-7896668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-78966682021-02-25 Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases Ma, Yan Cao, Xue Zhang, Li Zhang, Jin-Yu Qiao, Zu-Sha Feng, Wen-Li World J Clin Cases Case Report BACKGROUND: Chloracne is a rare skin condition that is caused by systemic exposure to halogenated aromatic compounds. The main characteristic of chloracne is blackhead, and in severe cases, it can be accompanied by systemic symptoms. Sodium 3,5,6-trichloropyridin-2-ol (STCP) is a necessary precursor compound for the production of chlorpyrifos and triclopyr, which are extensively used as a pesticide and herbicide, respectively. STCP is also a chlorophenol that has been associated with chloracne. STCP poisoning could induce mild myelin sheath damage. We herein report three cases with chloracne due to exposure to STCP. CASE SUMMARY: Three young men, aged 29, 33, and 26 years, respectively, in the same workplace had polymorphic skin lesions, characterized mainly by comedones and cysts, and one of them also had acne like lesions in the genital area. These clinical manifestations appeared when they were exposed to STCP for 3 d, 1 wk, and 2 wk, respectively. Among them, polyneuropathy and liver damage occurred. We performed dermoscopy and clinical and laboratory tests on these patients. Additionally, histopathology was used for further diagnosis in the serious patient. These patients were diagnosed with chloracne and separated from STCP. The patients were prescribed oral viaminate capsules, topical adapalene gel, and regular hematologic follow-up for aspartate transaminase and lipids. They are still under follow-up. There was no new lesions and the laboratory tests returned to normal in two patients. Pigmentation and shallow scars remained in the original areas of papules. However, in the most serious patient, new papules still appeared intermittently. All these remind us that the treatment of chloracne caused by STCP is difficult, and we should attach great importance to this new compound related with the neuropathy and chloracne. CONCLUSION: STCP is becoming a new chemical product to induce chloracne, which should attract the attention of all medical professionals, especially dermatologists. Due to the lack of knowledge on the new chemical, the diagnosis of chloracne cannot be made in time. Chloracne still deserves our attention. Baishideng Publishing Group Inc 2021-02-16 2021-02-16 /pmc/articles/PMC7896668/ /pubmed/33644170 http://dx.doi.org/10.12998/wjcc.v9.i5.1079 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Report Ma, Yan Cao, Xue Zhang, Li Zhang, Jin-Yu Qiao, Zu-Sha Feng, Wen-Li Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases |
title | Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases |
title_full | Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases |
title_fullStr | Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases |
title_full_unstemmed | Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases |
title_short | Neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: Report of three cases |
title_sort | neuropathy and chloracne induced by 3,5,6-trichloropyridin-2-ol sodium: report of three cases |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896668/ https://www.ncbi.nlm.nih.gov/pubmed/33644170 http://dx.doi.org/10.12998/wjcc.v9.i5.1079 |
work_keys_str_mv | AT mayan neuropathyandchloracneinducedby356trichloropyridin2olsodiumreportofthreecases AT caoxue neuropathyandchloracneinducedby356trichloropyridin2olsodiumreportofthreecases AT zhangli neuropathyandchloracneinducedby356trichloropyridin2olsodiumreportofthreecases AT zhangjinyu neuropathyandchloracneinducedby356trichloropyridin2olsodiumreportofthreecases AT qiaozusha neuropathyandchloracneinducedby356trichloropyridin2olsodiumreportofthreecases AT fengwenli neuropathyandchloracneinducedby356trichloropyridin2olsodiumreportofthreecases |